The Coronavirus Disease 2019 (COVID-19) vaccines licensed or authorized by the U.S. Food and Drug Administration (FDA) are a critical tool to reduce the spread and severity of COVID-19. FDA initially authorized the vaccines, between December 2020 and February 2021, under Section 564 of the Federal Food, Drug, and Cosmetic Act (FD&C Act), a regulatory … Read more
“Federal Regional Commissions and Authorities: Structural Features and Function,” CRS Report R45997, April 29, 2021 (59-page PDF) “Earmark Disclosure Rules in the Senate: Member and Committee Requirements,” CRS Report RS22867, April 28, 2021 (11-page PDF) “Apportionment and Redistricting Following the 2020 Census,” CRS Insight IN11360, April 27, 2021 (6-page PDF) “Jones v. Mississippi, the Eighth … Read more
The Coronavirus Disease 2019 (COVID-19) vaccines recently authorized by the U.S. Food and Drug Administration (FDA) are a critical tool to address the pandemic. After determining that these vaccines meet the applicable statutory standards and the Agency’s specific safety and efficacy standards, FDA issued Emergency Use Authorizations (EUAs) under Section 564 of the Federal Food, … Read more
Considering Legislation on the House Floor: Common Practices in Brief, CRS Report R43424, February 26, 2021 (13-page PDF) “Legislative Branch: FY2021 Appropriations,” CRS Report R46469, February 26, 2021 (40-page PDF) “Availability of Legislative Measures in the House of Representatives (The “72-Hour Rule”),” CRS Report RS22015, February 25, 2021 (12-page PDF) “U.S. Capitol Attack and Law … Read more